Evaluation of the leukocyte esterase test (LET) as pre-screening test to reduce costs for national population-based Chlamydia trachomatis screening programs.
Morré
Servaas A
SA
Spaargaren
Joke
J
Veldhuijzen
Irene K
IK
Postma
Maarten J
MJ
van Bergen
Jan E A M
JE
van Bergen
J E A M
JE
Broer
J
J
Coenen
A J J
AJ
Götz
H M
HM
de Groot
F
F
Hoebe
C J P A
CJ
Richardus
J H
JH
van Schaik
D T
DT
Veldhuijzen
I K
IK
Verhooren
M
M
D001681:Biological Assay / Q000191:economics / Q000379:methods; D002265:Carboxylic Ester Hydrolases / Q000032:analysis*; D002690:Chlamydia Infections / Q000175:diagnosis* / Q000191:economics; D002692:Chlamydia trachomatis / Q000472:pathogenicity; D003363:Cost Control; D004269:DNA, Bacterial / Q000032:analysis; D005260:Female; D006801:Humans; D008297:Male; D008403:Mass Screening / Q000191:economics* / Q000379:methods; D016133:Polymerase Chain Reaction
D004269:DNA, Bacterial; C021443:leukocyte esterase; D002265:Carboxylic Ester Hydrolases